Status:
COMPLETED
A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions:
Intra-abdominal Infection
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
On the basis of monotherapy for intra-abdominal infection, the investigators are conducting this study to identify the difference of drug efficacy between ampicillin/sulbactam and moxifloxacin.
Eligibility Criteria
Inclusion
- patients diagnosed of complicated intra-abdominal infection need surgical treatment
Exclusion
- patients diagnosed of intra-abdominal infection receive non-operative management
- patients with known allergic history of fluoroquinolone
- Severe, life threatening disease with a life expectancy of \< 48 h or APS and APACHE scores of \> 35
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00952796
Start Date
January 1 2009
End Date
December 1 2010
Last Update
August 2 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University Hospital, Department of Emergency Medicine/Surgery
Kaohsiung, Taiwan, Taiwan, 804